elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q43872776-1EE31136-3F53-4075-96D9-702D9594BFDD
Q43872776-1EE31136-3F53-4075-96D9-702D9594BFDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43872776-1EE31136-3F53-4075-96D9-702D9594BFDD
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
P356
Q43872776-1EE31136-3F53-4075-96D9-702D9594BFDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43872776-1EE31136-3F53-4075-96D9-702D9594BFDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
097e1d18e6749288705bb2fdeec3bb6f84ff7dd3
P356
10.1200/JCO.20.3.727
http://www.w3.org/2001/XMLSchema#string
P356
JCO.20.3.727